Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.

Murakami S, Saito H, Sakuma Y, Kondo T, Oshita F, Ito H, Tsuboi M, Hasegawa C, Yokose T, Kameda Y, Nakayama H, Yamada K.

Eur J Radiol. 2012 Aug;81(8):1891-5. doi: 10.1016/j.ejrad.2011.04.007.

PMID:
21546177
2.

Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.

Murakami S, Saito H, Sakuma Y, Mizutani Y, Ishikawa Y, Kondou T, Oshita F, Yokose T, Kameda Y, Suga Y, Ito H, Tsuboi M, Nakayama H, Noda K, Yamada K.

Eur J Radiol. 2010 Aug;75(2):e62-6. doi: 10.1016/j.ejrad.2009.11.020.

PMID:
20005653
3.

Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.

Hattori A, Suzuki K, Matsunaga T, Fukui M, Tsushima Y, Takamochi K, Oh S.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):329-34. doi: 10.1093/icvts/ivt500.

4.

Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.

Higuchi M, Hasegawa T, Osugi J, Suzuki H, Gotoh M.

Ann Thorac Cardiovasc Surg. 2014;20(3):185-91.

5.

[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].

Liu Y, Wu N, Bi GC, Zhang DS, Zheng R, Liang Y, Zhang WJ, Li XM, Fang Y.

Zhonghua Zhong Liu Za Zhi. 2016 Apr;38(4):263-9. doi: 10.3760/cma.j.issn.0253-3766.2016.04.005. Chinese.

PMID:
27087372
6.

Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1365-71. doi: 10.1016/j.jtcvs.2012.07.012.

7.

Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.

Chiu CH, Yeh YC, Lin KH, Wu YC, Lee YC, Chou TY, Tsai CM.

J Thorac Oncol. 2011 Oct;6(10):1697-703. doi: 10.1097/JTO.0b013e318226b677.

8.

Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?

Ito R, Iwano S, Kishimoto M, Ito S, Kato K, Naganawa S.

Ann Nucl Med. 2015 Dec;29(10):897-905. doi: 10.1007/s12149-015-1025-z.

PMID:
26342592
9.

¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.

Murakami S, Saito H, Karino F, Kondo T, Oshita F, Ito H, Nakayama H, Yokose T, Yamada K.

Eur J Radiol. 2013 Nov;82(11):e721-5. doi: 10.1016/j.ejrad.2013.07.028.

PMID:
23988690
10.

The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma.

Kim HR, Kim DJ, Lee WW, Jheon S, Sung SW.

Eur J Cardiothorac Surg. 2009 Apr;35(4):712-6; discussion 716-7. doi: 10.1016/j.ejcts.2008.12.030.

PMID:
19211260
11.

Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008.

12.

Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.

Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.

Biomed Mater Eng. 2014;24(6):3091-103. doi: 10.3233/BME-141131.

PMID:
25227018
13.

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS.

Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3.

14.

The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.

Maeda R, Isowa N, Onuma H, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y.

Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):70-3. doi: 10.1510/icvts.2009.202580.

PMID:
19359282
15.

Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT.

Kishimoto M, Iwano S, Ito S, Kato K, Ito R, Naganawa S.

Lung Cancer. 2014 Nov;86(2):180-4. doi: 10.1016/j.lungcan.2014.09.006.

PMID:
25263854
16.

Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

Ann Oncol. 2013 Sep;24(9):2376-81. doi: 10.1093/annonc/mdt230.

PMID:
23788749
17.
18.

F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.

Takahashi Y, Takashima S, Watanabe S, Tomita Y, Hakucho T, Miyake C, Morimoto D, Hosoki T, Nakanishi K, Higashiyama M.

Acta Radiol. 2013 Mar 1;54(2):164-8. doi: 10.1258/ar.2012.120138.

PMID:
23138022
19.

Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.

Nakamura H, Saji H, Shinmyo T, Tagaya R, Kurimoto N, Koizumi H, Takagi M.

Lung Cancer. 2015 Jan;87(1):28-33. doi: 10.1016/j.lungcan.2014.11.010.

PMID:
25481488
20.

Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.

Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.

Clin Lung Cancer. 2013 Sep;14(5):568-73. doi: 10.1016/j.cllc.2013.02.002.

PMID:
23835164

Supplemental Content

Support Center